The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Deficiency of PTEN in Jurkat T Cells Causes Constitutive Localization of Itk to the Plasma Membrane and Hyperresponsiveness to CD3 Stimulation
Open accessAbstract
Pleckstrin homology (PH) domain binding to D3-phosphorylated phosphatidylinositides (PI) provides a reversible means of recruiting proteins to the plasma membrane, with the resultant change in subcellular localization playing a key role in the activation of multiple intracellular signaling pathways. Previously we found that the T-cell-specific PH domain-containing kinase Itk is constitutively membrane associated in Jurkat T cells. This distribution was unexpected given that the closely related B-cell kinase, Btk, is almost exclusively cytosolic. In addition to constitutive membrane association of Itk, unstimulated JTAg T cells also exhibited constitutive phosphorylation of Akt on Ser-473, an indication of elevated basal levels of the phosphatidylinositol 3-kinase (PI3K) products PI-3,4-P(2) and PI-3,4,5-P(3) in the plasma membrane. Here we describe a defect in expression of the D3 phosphoinositide phosphatase, PTEN, in Jurkat and JTAg T cells that leads to unregulated PH domain interactions with the plasma membrane. Inhibition of D3 phosphorylation by PI3K inhibitors, or by expression of PTEN, blocked constitutive phosphorylation of Akt on Ser-473 and caused Itk to redistribute to the cytosol. The PTEN-deficient cells were also hyperresponsive to T-cell receptor (TCR) stimulation, as measured by Itk kinase activity, tyrosine phosphorylation of phospholipase C-gamma1, and activation of Erk compared to those in PTEN-replete cells. These data support the idea that PH domain-mediated association with the plasma membrane is required for Itk activation, provide evidence for a negative regulatory role of PTEN in TCR stimulation, and suggest that signaling models based on results from Jurkat T-cell lines may underestimate the role of PI3K in TCR signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cellular survival: a play in three Akts
Datta, S. R., Brunet, A., & Greenberg, M. E. (1999) · Genes & Development · doi:10.1101/gad.13.22.2905 · Cited by 4,216
Mechanism of activation of protein kinase B by insulin and IGF-1.
Alessi, D. R., Andjelkovic, M., Caudwell, B., Cron, P., Morrice, N., Cohen, P., & Hemmings, B. A. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01045.x · Cited by 3,004
Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
Stambolic, V., Suzuki, A., de la Pompa, J. L., Brothers, G. M., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, J. M., Siderovski, D. P., & Mak, T. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81780-8 · Cited by 2,551
Cantley, L. C., & Neel, B. G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4240 · Cited by 2,006
Monoclonal Antibodies Defining Distinctive Human T Cell Surface Antigens
Kung, P. C., Goldstein, G., Reinherz, E. L., & Schlossman, S. F. (1979) · Science · doi:10.1126/science.314668 · Cited by 1,453
Fruman, D. A., Meyers, R. E., & Cantley, L. C. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.481 · Cited by 1,355
The lipid phosphatase activity of PTEN is critical for its tumor supressor function
Myers, M. P., Pass, I., Batty, I. H., Van der Kaay, J., Stolarov, J. P., Hemmings, B. A., Wigler, M. H., Downes, C. P., & Tonks, N. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13513 · Cited by 1,168
Protein Kinase C Isotypes Controlled by Phosphoinositide 3-Kinase Through the Protein Kinase PDK1
Le Good, J. A., Ziegler, W. H., Parekh, D. B., Alessi, D. R., Cohen, P., & Parker, P. J. (1998) · Science · doi:10.1126/science.281.5385.2042 · Cited by 1,110
Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation
COFFER, P. J., JIN, J., & WOODGETT, J. R. (1998) · Biochemical Journal · doi:10.1042/bj3350001 · Cited by 1,067
Nuclear Export of NF-ATc Enhanced by Glycogen Synthase Kinase-3
Beals, C. R., Sheridan, C. M., Turck, C. W., Gardner, P., & Crabtree, G. R. (1997) · Science · doi:10.1126/science.275.5308.1930 · Cited by 754
Chan, T. O., Rittenhouse, S. E., & Tsichlis, P. N. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.965 · Cited by 737
Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase.
Powis, G., Bonjouklian, R., Berggren, M. M., Gallegos, A. C., Abraham, R. T., Ashendel, C. L., Zalkow, L. H., Matter, W. F., Dodge, J. A., & Grindey, G. B. (1994) · PubMed · Cited by 687
Signalling through phosphoinositide 3-kinases: the lipids take centre stage
Leevers, S. J., Vanhaesebroeck, B., & Waterfield, M. D. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80029-5 · Cited by 676
Marsh, D. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.3.507 · Cited by 653 · cited 1×
“Interestingly, PTEN mutations in this region are associated with many cases of Cowden disease and BannayanZonana syndrome—human disorders associated with loss of PTEN function (55).”
BackgroundRegulation of protein kinase C ζ by PI 3-kinase and PDK-1
Chou, M. M., Hou, W., Johnson, J., Graham, L. K., Lee, M. H., Chen, C.-S., Newton, A. C., Schaffhausen, B. S., & Toker, A. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70444-0 · Cited by 608
PTEN: a tumour suppressor that functions as a phospholipid phosphatase
Maehama, T. (1999) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01519-6 · Cited by 590
Ramaswamy, S., Nakamura, N., Vazquez, F., Batt, D. B., Perera, S., Roberts, T. M., & Sellers, W. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2110 · Cited by 575
Activation of phospholipase Cgamma by PI 3-kinase-induced PH domain-mediated membrane targeting
Falasca, M. (1998) · The EMBO Journal · doi:10.1093/emboj/17.2.414 · Cited by 564
Impaired Fas Response and Autoimmunity in Pten +/− Mice
Cristofano, A. D., Kotsi, P., Peng, Y. F., Cordon-Cardo, C., Elkon, K. B., & Pandolfi, P. P. (1999) · Science · doi:10.1126/science.285.5436.2122 · Cited by 521
Akt/Protein Kinase B Is Regulated by Autophosphorylation at the Hypothetical PDK-2 Site
Toker, A., & Newton, A. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8271 · Cited by 516
Li, D.-M., & Sun, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15406 · Cited by 489
Haas-Kogan, D., Shalev, N., Wong, M., Mills, G., Yount, G., & Stokoe, D. (1998) · Current Biology · doi:10.1016/s0960-9822(07)00493-9 · Cited by 477
Scharenberg, A. M., El-Hillal, O., Fruman, D. A., Beitz, L. O., Li, Z., Lin, S., Gout, I., Cantley, L. C., Rawlings, D. J., & Kinet, J.-P. (1998) · The EMBO Journal · doi:10.1093/emboj/17.7.1961 · Cited by 429
Binding of phosphatidyl-inositol-3-OH kinase to CD28 is required for T-cell signalling
Pagès, F., Ragueneau, M., Rottapel, R., Truneh, A., Nunes, J., Imbert, J., & Olive, D. (1994) · Nature · doi:10.1038/369327a0 · Cited by 398
Requirement for Tec Kinases Rlk and Itk in T Cell Receptor Signaling and Immunity
Schaeffer, E. M., Debnath, J., Yap, G., McVicar, D., Liao, X. C., Littman, D. R., Sher, A., Varmus, H. E., Lenardo, M. J., & Schwartzberg, P. L. (1999) · Science · doi:10.1126/science.284.5414.638 · Cited by 398
Self-citationFurnari, F. B., Huang, H., & Cavenee, W. K. (1998) · PubMed · Cited by 395
Regulation of conventional protein kinase C isozymes by phosphoinositide-dependent kinase 1 (PDK-1)
Dutil, E. M., Toker, A., & Newton, A. C. (1998) · Current Biology · doi:10.1016/s0960-9822(98)00017-7 · Cited by 381
Liu, K.-Q., Bunnell, S. C., Gurniak, C. B., & Berg, L. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.10.1721 · Cited by 339
Self-citationThe tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region
Georgescu, M.-M., Kirsch, K. H., Akagi, T., Shishido, T., & Hanafusa, H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10182 · Cited by 317
Altered T cell receptor signaling and disrupted T cell development in mice lacking Itk
Liao, X. C., & Littman, D. R. (1995) · Immunity · doi:10.1016/1074-7613(95)90065-9 · Cited by 315
Impaired NFATc Translocation and Failure of Th2 Development in Itk-Deficient CD4+ T Cells
Fowell, D. J., Shinkai, K., Liao, X. C., Beebe, A. M., Coffman, R. L., Littman, D. R., & Locksley, R. M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80115-6 · Cited by 306
Várnai, P., Rother, K. I., & Balla, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.10983 · Cited by 295
PLECKSTRIN HOMOLOGY DOMAINS: A Common Fold with Diverse Functions
Rebecchi, M. J., & Scarlata, S. (1998) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.27.1.503 · Cited by 291
Biochemical Interactions Integrating Itk with the T Cell Receptor-initiated Signaling Cascade
Bunnell, S. C., Diehn, M., Yaffe, M. B., Findell, P. R., Cantley, L. C., & Berg, L. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.3.2219 · Cited by 280
Self-citationDavies, M. A., Koul, D., Dhesi, H., Berman, R. S., McDonnell, T. J., McConkey, D. J., Yung, W. K. A., & Steck, P. A. (1999) · PubMed · Cited by 280
Jimenez, C. (1998) · The EMBO Journal · doi:10.1093/emboj/17.3.743 · Cited by 269
Scharenberg, A. M., & Kinet, J.-P. (1998) · Cell · doi:10.1016/s0092-8674(00)81214-3 · Cited by 220
Tyrosine phosphorylation and activation of Bruton tyrosine kinase upon Fc epsilon RI cross-linking.
Kawakami, Y., Yao, L., Miura, T., Tsukada, S., Witte, O. N., & Kawakami, T. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.8.5108 · Cited by 213
Li, Z., Wahl, M. I., Eguinoa, A., Stephens, L. R., Hawkins, P. T., & Witte, O. N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13820 · Cited by 184
August, A., Sadra, A., Dupont, B., & Hanafusa, H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11227 · Cited by 177
PTEN Gene Alterations in Lymphoid Neoplasms
Sakai, A., Thieblemont, C., Wellmann, A., Jaffe, E. S., & Raffeld, M. (1998) · Blood · doi:10.1182/blood.v92.9.3410 · Cited by 174
Heyeck, S. D., Wilcox, H. M., Bunnell, S. C., & Berg, L. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25401 · Cited by 171
Self-citationThe PH superfold: a structural scaffold for multiple functions
Blomberg, N., Baraldi, E., Nilges, M., & Saraste, M. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01472-3 · Cited by 166
Tec family of protein-tyrosine kinases: an overview of their structure and function
Mano, H. (1999) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(99)00019-2 · Cited by 162
Cai, Y.-C., Céfaï, D., Schneider, H., Raab, M., Nabavi, N., & Rudd, C. E. (1995) · Immunity · doi:10.1016/1074-7613(95)90171-x · Cited by 131
PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis
Besson, A., Robbins, S. M., & Yong, V. W. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00542.x · Cited by 130
Phosphoinositide Binding Domains
Fruman, D. A., Rameh, L. E., & Cantley, L. C. (1999) · Cell · doi:10.1016/s0092-8674(00)80792-8 · Cited by 129
The Btk subfamily of cytoplasmic tyrosine kinases: structure, regulation and function
Rawlings, D. J. (1995) · Seminars in Immunology · doi:10.1006/smim.1995.0028 · Cited by 127
Andjelković, M., Maira, S.-M., Cron, P. D., Parker, P. J., & Hemmings, B. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.5061 · Cited by 121
Exley, M. A., Varticovski, L., Peter, M. E., Sancho, J., & Terhorst, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36584-5 · Cited by 120
Häusler, P., Papoff, G., Eramo, A., Reif, K., Cantrell, D. A., & Ruberti, G. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199801)28:01<57::aid-immu57>3.0.co;2-8 · Cited by 113
Ward, S. G., Ley, S. C., Macphee, C. H., & Cantrell, D. A. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220108 · Cited by 112
Wick, W., Furnari, F. B., Naumann, U., Cavenee, W. K., & Weller, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202774 · Cited by 111
Bad Can Act as a Key Regulator of T Cell Apoptosis and T Cell Development
Mok, C.-L., Gil‐Gómez, G., Williams, O., Coles, M. C., Taga, S., Tolaini, M., Norton, T., Kioussis, D., & Brady, H. J. M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.575 · Cited by 111
Rawlings, D. J. (1999) · Clinical Immunology · doi:10.1006/clim.1999.4732 · Cited by 110
Shan, X., & Wange, R. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.41.29323 · Cited by 108
Self-citationBurkhardt, A. L., Stealey, B. A., Rowley, R. B., Mahajan, S., Prendergast, M., Fargnoli, J., & Bolen, J. B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31563-6 · Cited by 105
A highly conserved processed PTEN pseudogene is located on chromosome band 9p21
Dahia, P. L., FitzGerald, M. G., Zhang, X., Marsh, D. J., Zheng, Z., Pietsch, T., von Deimling, A., Haluska, F. G., Haber, D. A., & Eng, C. (1998) · Oncogene · doi:10.1038/sj.onc.1201762 · Cited by 99
Transcriptional analysis of the PTEN/MMAC1 pseudogene, ΨPTEN
Fujii, G. H., Morimoto, A. M., Berson, A. E., & Bolen, J. B. (1999) · Oncogene · doi:10.1038/sj.onc.1202492 · Cited by 84
Ward, S. G., Wilson, A., Turner, L., Westwick, J. K., & Sansom, D. M. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250233 · Cited by 74
Constitutive membrane association potentiates activation of Bruton tyrosine kinase
Li, T., Rawlings, D. J., Park, H., Kato, R. M., Witte, O. N., & Satterthwaite, A. B. (1997) · Oncogene · doi:10.1038/sj.onc.1201308 · Cited by 72
Eder, A. M., Dominguez, L., Franke, T. F., & Ashwell, J. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.43.28025 · Cited by 68
von Willebrand, M., Jascur, T. A., Bonnefoy, N., Yano, H., Altman, A., Matsuda, Y., & Mustelin, T. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.00828.x · Cited by 68
Emt/Itk Associates with Activated TCR Complexes: Role of the Pleckstrin Homology Domain
Ching, K. A., Kawakami, Y., Kawakami, T., & Tsoukas, C. D. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.11.6006 · Cited by 65
Truitt, K. E., Shi, J., Gibson, S. B., Segal, L., Mills, G. B., & Imboden, J. B. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.10.4702 · Cited by 62
Kim, S. K., Su, L.-K., Oh, Y. W., Kemp, B. L., Hong, W. K., & Mao, L. (1998) · Oncogene · doi:10.1038/sj.onc.1201512 · Cited by 61
Hutchcroft, J. E., & Bierer, B. E. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.11.4071 · Cited by 59
de Aós, I., Metzger, M. H., Exley, M. A., Dahl, C. E., Misra, S., Zheng, D., Varticovski, L., Terhorst, C., & Sancho, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25310 · Cited by 55
Carrera, A. C., Rodrı́guez-Borlado, L., Martínez-Alonso, C., & Mérida, I. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32187-7 · Cited by 46
Shi, J., Cinek, T., Truitt, K. E., & Imboden, J. B. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.10.4688 · Cited by 46
Lu, Y., Phillips, C. A., & Trevillyan, J. M. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250234 · Cited by 46
Lu, Y., Cuevas, B. D., Gibson, S. B., Khan, H., LaPushin, R., Imboden, J. B., & Mills, G. B. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.10.5404 · Cited by 43
Hutchcroft, J. E., Franklin, D. P., Tsai, B., Harrison-Findik, D. D., Varticovski, L., & Bierer, B. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8808 · Cited by 34
Cited by
The CD28 Signaling Pathway Regulates Glucose Metabolism
Frauwirth, K. A., Riley, J. L., Harris, M. H., Parry, R. V., Rathmell, J. C., Plas, D. R., Elstrom, R. L., June, C. H., & Thompson, C. B. (2002) · Immunity · doi:10.1016/s1074-7613(02)00323-0 · Cited by 1,475
Chemnitz, J. M., Parry, R. V., Nichols, K. E., June, C. H., & Riley, J. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.945 · Cited by 1,246
T-cell regulation by CD28 and CTLA-4
Alegre, M.-L., Frauwirth, K. A., & Thompson, C. B. (2001) · Nature Reviews Immunology · doi:10.1038/35105024 · Cited by 914
PD-1 signaling in primary T cells
Riley, J. L. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00767.x · Cited by 778
“Furthermore, transformed cell lines like Jurkat are defective in signaling molecules such as phosphatase and tensin homolog (PTEN) and Ship that oppose uncontrolled growth (81, 82).”
BackgroundHepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
Horie, Y., Suzuki, A., Kataoka, E., Sasaki, T., Hamada, K., Sasaki, J., Mizuno, K., Hasegawa, G., Kishimoto, H., Iizuka, M., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420513 · Cited by 698
Metadata
- Authors
- Shan, X., Czar, M. J., Bunnell, S. C., Liu, P., Liu, Y., Schwartzberg, P. L., & Wange, R. L.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2000-09-01
- Volume
- 20
- Issue
- 18
- Pages
- 6945-6957
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2138421443
- Cited by
- 350
- References
- 73
- FWCI
- 11.83
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.